This inventor holds 1 USPTO granted patent. Top assignee: Angiochem Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Stephane Barakat: Inventor in P-glycoprotein Research
Introduction
Stephane Barakat is an inventor associated with Angiochem Inc. in Montreal, Canada. His patent work concerns P-glycoprotein, a protein involved in transporting compounds out of cells.
Latest Patents
Barakat is credited with 1 patent: “Compounds for Stimulating P-glycoprotein Function and Uses Thereof.” The invention describes polypeptides derived from P-glycoprotein and caveolin-1 that can inhibit the interaction between the two proteins. By inhibiting this interaction, the approach aims to increase the efflux of compounds transported by P-glycoprotein. The patent also describes potential treatment methods for conditions that may benefit from increased P-glycoprotein-mediated efflux, including cancer and neurological diseases such as neurodegenerative disorders.
Career Highlights
Barakat’s listed invention reflects research into protein interactions and their possible therapeutic applications. His work is associated with Angiochem Inc., a company focused on developing therapeutic approaches.
Collaborations
Barakat’s listed coworkers include Richard Beliveau and Michel Demeule. Their names are associated with the research and patent information provided for this invention.
Conclusion
Stephane Barakat’s patent work explores a potential way to influence P-glycoprotein activity, with proposed applications in cancer and neurological disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile